Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
15.95
28.5
|
| Price Target |
|
We'll email you a reminder when the closing price reaches TRY.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Intrinsic Value
The intrinsic value of one TRILC.E stock under the Base Case scenario is hidden TRY. Compared to the current market price of 16.84 TRY, Turk Ilac ve Serum Sanayi AS is hidden .
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Turk Ilac ve Serum Sanayi AS
TRILC.E looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if TRILC.E is one of them.
Learn how current stock valuations stack up against historical averages to gauge true investment potential.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Turk Ilac ve Serum Sanayi AS.
| US |
|
Eli Lilly and Co
NYSE:LLY
|
|
| UK |
|
Dechra Pharmaceuticals PLC
LSE:DPH
|
|
| US |
|
Johnson & Johnson
NYSE:JNJ
|
|
| CH |
|
Roche Holding AG
SIX:ROG
|
|
| UK |
|
AstraZeneca PLC
LSE:AZN
|
|
| CH |
|
Novartis AG
SIX:NOVN
|
|
| US |
|
Merck & Co Inc
NYSE:MRK
|
|
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
|
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Fundamental Analysis
Select up to 3 indicators:
Select up to 3 indicators:
Revenue & Expenses Breakdown
Turk Ilac ve Serum Sanayi AS
Balance Sheet Decomposition
Turk Ilac ve Serum Sanayi AS
| Current Assets | 2.9B |
| Cash & Short-Term Investments | 17.7m |
| Receivables | 1.9B |
| Other Current Assets | 909.3m |
| Non-Current Assets | 2.2B |
| Long-Term Investments | 285m |
| PP&E | 1.9B |
| Intangibles | 7.4m |
| Other Non-Current Assets | -430k |
| Current Liabilities | 2.5B |
| Accounts Payable | 404m |
| Accrued Liabilities | 122m |
| Short-Term Debt | 633m |
| Other Current Liabilities | 1.3B |
| Non-Current Liabilities | 976m |
| Long-Term Debt | 798m |
| Other Non-Current Liabilities | 178m |
Free Cash Flow Analysis
Turk Ilac ve Serum Sanayi AS
| TRY | |
| Free Cash Flow | TRY |
Earnings Waterfall
Turk Ilac ve Serum Sanayi AS
|
Revenue
|
2.8B
TRY
|
|
Cost of Revenue
|
-1.9B
TRY
|
|
Gross Profit
|
875m
TRY
|
|
Operating Expenses
|
-262m
TRY
|
|
Operating Income
|
613m
TRY
|
|
Other Expenses
|
-1.2B
TRY
|
|
Net Income
|
-566.3m
TRY
|
TRILC.E Profitability Score
Profitability Due Diligence
Turk Ilac ve Serum Sanayi AS's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
Turk Ilac ve Serum Sanayi AS's profitability score is hidden . The higher the profitability score, the more profitable the company is.
TRILC.E Solvency Score
Solvency Due Diligence
Turk Ilac ve Serum Sanayi AS's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
Turk Ilac ve Serum Sanayi AS's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
TRILC.E Price Targets Summary
Turk Ilac ve Serum Sanayi AS
Dividends
Current shareholder yield for TRILC.E is hidden .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one TRILC.E stock under the Base Case scenario is hidden TRY.
Compared to the current market price of 16.84 TRY, Turk Ilac ve Serum Sanayi AS is hidden .